TrialEuropean journal of clinical pharmacology2022

Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Akiko Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.